These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 25766890

  • 1. Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
    Bhowmick M, Stawikowska R, Tokmina-Roszyk D, Fields GB.
    Chembiochem; 2015 May 04; 16(7):1084-92. PubMed ID: 25766890
    [Abstract] [Full Text] [Related]

  • 2. Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
    Lauer-Fields J, Brew K, Whitehead JK, Li S, Hammer RP, Fields GB.
    J Am Chem Soc; 2007 Aug 29; 129(34):10408-17. PubMed ID: 17672455
    [Abstract] [Full Text] [Related]

  • 3. Matrix Metalloproteinase Triple-Helical Peptide Inhibitors: Potential Cross-Reactivity with Caspase-11.
    Knapinska AM, Hart M, Drotleff G, Fields GB.
    Molecules; 2019 Nov 28; 24(23):. PubMed ID: 31795279
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Methods for the Construction of Collagen-Based Triple-Helical Peptides Designed as Matrix Metalloproteinase Inhibitors.
    Fields GB.
    Methods Mol Biol; 2019 Nov 28; 1944():229-252. PubMed ID: 30840247
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
    Minond D, Lauer-Fields JL, Cudic M, Overall CM, Pei D, Brew K, Visse R, Nagase H, Fields GB.
    J Biol Chem; 2006 Dec 15; 281(50):38302-13. PubMed ID: 17065155
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.
    Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB.
    Bioorg Med Chem; 2009 Feb 01; 17(3):990-1005. PubMed ID: 18358729
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ, Stawikowska R, Fields GB.
    Biochemistry; 2015 May 19; 54(19):3110-21. PubMed ID: 25897652
    [Abstract] [Full Text] [Related]

  • 14. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
    Lauer-Fields JL, Broder T, Sritharan T, Chung L, Nagase H, Fields GB.
    Biochemistry; 2001 May 15; 40(19):5795-803. PubMed ID: 11341845
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Roles of Matrix Metalloproteinases in Pancreatic Cancer.
    Knapinska AM, Estrada CA, Fields GB.
    Prog Mol Biol Transl Sci; 2017 May 15; 148():339-354. PubMed ID: 28662827
    [Abstract] [Full Text] [Related]

  • 17. Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).
    Higashi S, Hirose T, Takeuchi T, Miyazaki K.
    J Biol Chem; 2013 Mar 29; 288(13):9066-76. PubMed ID: 23395821
    [Abstract] [Full Text] [Related]

  • 18. The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.
    Fields GB.
    Cells; 2019 Aug 27; 8(9):. PubMed ID: 31461880
    [Abstract] [Full Text] [Related]

  • 19. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL, Zhang B, Zheng MH, Xie YZ, Wang CJ, Jin JY.
    Curr Top Med Chem; 2020 Aug 27; 20(27):2459-2471. PubMed ID: 32703131
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
    Hurst DR, Schwartz MA, Jin Y, Ghaffari MA, Kozarekar P, Cao J, Sang QX.
    Biochem J; 2005 Dec 15; 392(Pt 3):527-36. PubMed ID: 16026329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.